Augmedix Inc
NASDAQ:AUGX
Net Margin
Augmedix Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Augmedix Inc
NASDAQ:AUGX
|
115.3m USD |
-46%
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
45.4B USD |
27%
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
29B AUD |
52%
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
11.4B USD |
39%
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.4T JPY |
14%
|
|
| SE |
|
Sectra AB
STO:SECT B
|
64.9B SEK |
27%
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.8B USD |
3%
|
|
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
3.9B USD |
8%
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
266.9B INR | N/A | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
21.1B CNY |
3%
|
Augmedix Inc
Glance View
Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Augmedix Inc's most recent financial statements, the company has Net Margin of -46.2%.
You don't have any saved screeners yet